The other ingredients are Glucose Anhydrous, Dispersible Cellulose, Polysorbate 80, Benzalkonium Chloride, Disodium Edetate, Purified Water

Human drug compounding, Food and Drug Administration (2024) Compounding when drugs are on FDAs drug shortages list, Food and Drug Administration (2024) FDA drug shortages: Semaglutide injection, Food and Drug Administration FDA alerts health care providers, compounders and patients of dosing errors associated with compounded injectable semaglutide products, Food and Drug Administration (2024) FDAs concerns with unapproved GLP-1 drugs used for weight loss, Food and Drug Administration (2024) Ozempic, DailyMed (2024) Find out if your insurance covers Ozempic, Novo Nordisk FDA warns patients and health care professionals not to use compounded drugs from Fullerton Wellness, Food and Drug Administration (2024) Company statement: Novo Nordisk escalates legal actions to safeguard patients from potentially harmful compounded semaglutide drugs, Novo Nordisk (2024) FDA clarifies policies for compounders as national GLP-1 supply begins to stabilize, Food and Drug Administration (2025) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice

Get in touch with our team today to book your consultation in Brampton, Toronto, or Kitchener.
Neurovasc Res
Prescription GLP-1 receptor agonists - semaglutide, liraglutide, tirzepatide - are FDA-approved medications with extensive clinical trial evidence for efficacy in type 2 diabetes and chronic weight management